SEC Form D · Amendment · filed December 1, 2022
Equilibre BioPharmaceuticals Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Francois A. Maisonrouge · New York, NYDirectorChristina A. Ramirez · New York, NYDirectorChristopher M. Thorn · New York, NYExecDavid A. Friedman · New York, NYDirectorPeter M. Simon · New York, NYDirectorSteven N. Gordon · New York, NYExec · DirectorPhilip A. Barach · New York, NYExec · DirectorPaul P. Bashir · London, United KingdomDirectorPascal E. Christory · Puteaux, I0DirectorJoost J. Knabben · Luxembourg City, LuxembourgDirectorLisa Y. Gokongwei · Grand Cayman, Cayman IslandsDirectorPeyman J. Azari · Luxembourg City, LuxembourgExec · DirectorDavid Hardie · Reno, NVExecStefan J. Corthouts · Canach, LuxembourgExec · DirectorDaniel Schulte · Overland Park, KSDirectorJames Maffuccio · Overland Park, KSDirectorBen Fraser · Overland Park, KSDirectorKimberly Melen · Grand Cayman, Cayman IslandsExec · DirectorLouise Groom · Grand Cayman, Cayman IslandsExec · DirectorJustin Smithline · Chadds Ford, PAExecAndrew T. Gi · Dallas, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗